The Food and Drug Administration (FDA) has approved the Taltz injection to treat adults with moderate-to-severe psoriasis.
Global pharmaceutical company Allergan has received approval from the FDA for a topical acne treatment.
Breast implant manufacturer Mentor has received Food and Drug Administration (FDA) and Investigational Device Exemption (IDE) approval to initiate a clinical trial studying larger breast implants.
Pharmaceutical manufacturer mesoestetic Pharma Group will launch a new acne line called acnelan at an international event in Barcelona on December 3 and 4.
Biotechnology company StemCutis LLC has enrolled the first three subjects of its phase 1/2 clinical trial, which will determine the safety of a single injection of allogeneic mesenchymal bone marrow cells (aMBMC) for the treatment of cutaneous photoageing.
The Food and Drug Administration (FDA) has approved the use of adalimumab (Humira) in adults with moderate to severe hidradenitis suppurativa (HS).
Skincare brand Innovative Skincare (iS) Clinical has launched two new additions to its range of paraben-free products, which aim to stimulate collagen-synthesis and minimise pore size.
The Food and Drug administration (FDA) has given approval to the use of an azelaic acid foam for the topical treatment of rosacea.
US hair loss technology provider Kerastem Technologies has received conditional FDA approval to conduct a clinical trial on the safety of the company’s treatment.
The FDA has given market approval to Restylane Lyft with lidocaine for cheek augmentation, an injectable gel that aims to increase volume and smooth facial wrinkles.